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SUMMARY 
Ligand-mediated dimerization has emerged as a universal mechanism of growth factor 
receptor activation. Neurotrophins interact with dimers of the p75 neurotrophin 
receptor (p75NTR), but the mechanism of receptor activation has remained elusive. Here 
we show that p75NTR forms disulphide-linked dimers independently of neurotrophin 
binding through the highly conserved Cys257 in its transmembrane domain. Mutation of 
Cys257 abolished neurotrophin-dependent receptor activity but did not affect 
downstream signaling by the p75NTR/NgR/Lingo-1 complex in response to MAG, 
indicating the existence of distinct, ligand-specific activation mechanisms for p75NTR. 
FRET experiments revealed a close association of p75NTR intracellular domains that 
was transiently disrupted by conformational changes induced upon NGF binding. 
Although mutation of Cys257 did not alter the oligomeric state of p75NTR, the mutant 
receptor was no longer able to propagate conformational changes to the cytoplasmic 
domain upon ligand binding. We propose that neurotrophins activate p75NTR by a 
mechanism involving rearrangement of disulphide-linked receptor subunits.  
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INTRODUCTION 
The neurotrophins are a family of neurotrophic factors that control multiple aspects of 
nervous system development and function, including neurogenesis, neuronal 
differentiation, cell survival, neurite outgrowth, target innervation and synaptic plasticity 
(Bibel and Barde, 2000). Four neurotrophins are present in mammals: nerve growth 
factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and 
neurotrophin-4 (NT-4). The neurotrophins are synthesized as a pre-pro-peptide from 
which the mature portion is released by proteolytic cleavage. The mature forms of 
neurotrophins interact with two distinct receptors, a cognate member of the Trk 
receptor tyrosine kinase family and the common p75 neurotrophin receptor (p75NTR), a 
member of the Tumor Necrosis Factor Receptor (TNFR) superfamily of death receptors 
(Friedman and Greene, 1999; Kaplan and Miller, 2000; Lee et al., 2001a; Patapoutian 
and Reichardt, 2001). On the other hand, unprocessed neurotrophins (pro-
neurotrophins) are thought to display selectivity for p75NTR over Trk receptors (Lee et 
al., 2001b) with the aid of the co-receptor sortilin (Nykjaer et al., 2004). While this 
interaction is thought to preferentially lead to cell death (Lee et al., 2001b), cell survival 
is mediated by Trk signaling (Patapoutian and Reichardt, 2001). A key issue in 
neurotrophin research is the elucidation of the molecular mechanisms underlying each 
of the physiological actions of the neurotrophins in different cell types, throughout 
development, and in pathological situations.  
Unlike Trk receptors, p75NTR lacks catalytic activity. The intracellular region of p75NTR 
contains a flexible juxtamembrane segment followed by a globular domain known as 
the death domain (Liepinsh et al., 1997). Signal transduction by p75NTR is thought to 
proceed via ligand-dependent recruitment and release of cytoplasmic effectors to and 
from the receptor. Over 20 different intracellular interactors of p75NTR have been 
identified to date (Barker, 2004; Bronfman and Fainzilber, 2004; Dechant and Barde, 
2002; Roux and Barker, 2002), but this wealth of interactions has not translated in a 
comparable understanding of receptor function. Some of the major downstream 
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signaling events triggered by p75NTR in response to neurotrophins include activation of 
NF-κB (Carter et al., 1996), c-jun kinase (JNK) (Friedman, 2000; Yoon et al., 1998), and 
caspases (Troy et al., 2002). In addition, p75NTR can also activate the small GTPase 
RhoA (Yamashita et al., 1999), but this requires a different set of ligands derived from 
myelin, such as myelin-associated glycoprotein (MAG) and Nogo (Wang et al., 2002; 
Wong et al., 2002; Yamashita et al., 2002), and two different co-receptors: a lipid-
anchored ligand-binding subunit known as the Nogo receptor (NgR) (Fournier et al., 
2001) and Lingo-1 (Mi et al., 2004). In addition, p75NTR is also known to undergo 
proteolytic cleavage upon activation by several of its ligands or induction of membrane 
metalloproteases with phorbol esters (Jung et al., 2003; Kanning et al., 2003). The 
release of the p75NTR intracellular domain following intramembrane cleavage by γ-
secretase is thought to be required for activation of some signaling pathways, such as 
NRIF-mediated neuronal death of sympathetic neurons (Kenchappa et al., 2006).  
Receptor oligomerization has been recognized as a crucial step in the activation of 
many plasma membrane receptors. In receptors carrying intrinsic kinase activity, 
ligand-mediated dimerization stabilizes the active conformation of the kinase domain 
by receptor trans-phosphorylation (Schlessinger, 2002). In non-catalytic receptors, 
such as cytokine and death receptors, oligomerization of intracellular domains results 
in recruitment of adaptors or activation of intracellularly bound effectors (Ashkenazi 
and Dixit, 1999; Constantinescu et al., 1999). However, while necessary, receptor 
oligomerization may not always be sufficient for signaling. Several studies have 
indicated that some cytokine and growth factor receptors exist in a pre-assembled 
dimeric complex prior to ligand stimulation, and that receptor activation results from a 
ligand-mediated change in the relative orientation of the two receptor protomers (Jiang 
and Hunter, 1999; Seubert et al., 2003).  
Although p75NTR was discovered over 20 years ago, and has since been intensively 
studied, its mechanism of activation has remained mysterious. Numerous studies have 
reported crosslinking of radiolabeled neurotrophins to p75NTR dimers and higher-order 
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oligomers (Hempstead et al., 1991; Mahadeo et al., 1994; Rydén et al., 1997b), 
demonstrating the ability of these ligands to directly bind oligomeric forms of this 
receptor. Based on this evidence, and the dimeric nature of neurotrophins, it has been 
assumed that these ligands activate p75NTR by classical ligand-mediated dimerization. 
A recent study has brought support to this notion by solving the x-ray crystal structure 
of a 2:2 complex between NT-3 and p75NTR (Gong et al., 2008). In the same work, a 2:2 
complex between NGF and p75NTR could also be purified, and it was shown that the 
glycosylated extracellular domain of p75NTR is monomeric in solution in the absence of 
ligand, suggesting a general model of p75NTR dimerization by all neurotrophins. In the 
present study, we investigated and characterized endogenous determinants of 
receptor dimerization. We discovered that full-length p75NTR forms disulphide-linked 
dimers in the absence of neurotrophins through the highly conserved Cys257 in its 
transmembrane domain. Functional analysis of a p75NTR mutant lacking Cys257 revealed 
the functional importance of disulphide-mediated receptor dimerization and suggested 
a novel mechanism of p75NTR activation by neurotrophins.  
 
RESULTS 
Transmembrane Cys257 mediates formation of disulphide-linked p75NTR dimers 
Surface expression of p75NTR was assessed in transfected cells following biotinylation 
of cell surface proteins, immunoprecipitation and gel electrophoresis under non-
reducing and reducing conditions. This analysis revealed that wild type p75NTR forms 
disulphide-linked dimers in the plasma membrane of transfected cells (Figure 1A). At 
high levels of expression in COS-7 cells, comparable amounts of cell surface p75NTR 
monomers and disulphide-linked dimers could be detected under non-reducing 
conditions (Figure 1A). However, the proportion of disulphide-linked p75NTR dimers in 
transfected cells depended upon the level of expression of the receptor. At moderate 
overexpression levels, less than 10% of wild type p75NTR was disulphide-linked (Figure 
1B). NGF treatment had no effect on the proportion of disulphide-linked p75NTR dimers 
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(data not shown). Since neither the extracellular (Gong et al., 2008; He and Garcia, 
2004) or intracellular (Liepinsh et al., 1997) domains of p75NTR have been reported to 
form disulphide-linked dimers, we turned our attention to the transmembrane domain 
of the receptor, which contains a Cys residue (Cys257) that is absolutely conserved in all 
p75NTR orthologs known to date, from echinoderms to mammals (Bothwell, 2006) 
(Figure 1C). Mutation of Cys257 to Alanine (C257A) abolished the ability of p75NTR to 
form disulphide-linked dimers (Figure 1A), indicating that such dimers are generated by 
disulphide bonding of two p75NTR molecules through Cys257 in the transmembrane 
domain. Disulphide-linked dimers could also be detected to varying degrees on the 
surface of cells endogenously expressing p75NTR, such as PC12 pheochromocytoma, 
RN22 Schwannoma and sympathetic neurons from the rat superior cervical ganglion 
(SCG) (Figure 1D), as well as in total extracts of newborn cortex, hippocampus and 
cerebellum (Figure 1E). Interestingly, in the latter cases the majority of p75NTR was 
disulphide-linked. Of note, a previous study found high levels of disulphide-linked 
p75NTR dimers in one melanoma cell line (A875) but not in another (HS294) (Grob et al., 
1985). Importantly, the C257A mutation did not affect the ability of p75NTR to bind NGF 
(Figure 1F), nor its capacity to undergo γ-secretase-dependent intramembrane 
cleavage upon stimulation with the phorbol ester PMA (Figure 1G).  
Cys257 is essential for p75NTR signaling in response to neurotrophins 
The ability of native p75NTR to form disulphide-linked dimers prompted the question of 
its possible significance to p75NTR activation and downstream signaling. We therefore 
investigated the effects of the C257A mutation on the ability of the receptor to recruit 
intracellular effectors and activate downstream pathways in response to NGF. Unlike 
wild type p75NTR, the C257A mutant was unable to interact with NRIF, either in the 
presence or absence of NGF (Figure 2A). Although a weak interaction could be 
observed between the C257A mutant and TRAF6, this was not increased by NGF 
treatment, which on the other hand readily promoted TRAF6 recruitment to wild type 
receptors (Figure 2B). These data suggested that, although wild type p75NTR is present 
as both monomers and disulphide-linked dimers at the cell membrane, only the latter 
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appear to be capable of recruiting downstream effectors such as NRIF and TRAF6 in a 
ligand-dependent manner. In order to address this directly, we tested the ability of 
NRIF and TRAF6 to differentially interact with monomers and disulphide-linked dimers 
of wild type p75NTR by analyzing pull-down products under reducing and non-reducing 
conditions. We found that NRIF interacted exclusively with disulphide-linked p75NTR 
dimers, but not at all with monomers, and NGF treatment could readily increase this 
interaction (Figure 2C). On the other hand, although TRAF6 could pull-down both 
p75NTR monomers and dimers, NGF treatment only stimulated TRAF6 binding to p75NTR 
dimers, but not monomers (Figure 2D). Also in sympathetic neurons from rat SCG, 
NRIF interacted only with p75NTR disulphide-linked dimers, not with monomers, and 
BDNF treatment strongly stimulated NRIF recruitment to the receptor (Figure 2E).  
We also examined three different downstream readouts of p75NTR activity in transfected 
fibroblasts and 293 cells, including activation of NF-κB (Figure 3A), caspase-3 (Figure 
3B), and induction of cell death (Figure 3C) in response to NGF. In all cases, the C257A 
mutant was unresponsive to stimulation, indicating that Cys257 is required for 
neurotrophin-dependent p75NTR signaling and downstream biological effects.  
In order to probe the functional importance of Cys257 for p75NTR signaling in a more 
physiological context, we developed two shRNA constructs directed to 3’ UTR 
sequences of the rat p75NTR mRNA to knock-down endogenous p75NTR expression in 
neurons. When introduced together into primary cultures of rat SCG neurons, these 
shRNAs effectively suppressed endogenous p75NTR expression, while a control shRNA 
had no effect (Figure 4A). As expected, control shRNA did not affect the ability of 
BDNF to induce JNK phosphorylation (Figure 4B) and cell death (Figure 4C) in SCG 
neurons, which express p75NTR and TrkA but not TrkB. In contrast, shRNAs directed 
against p75NTR abolished both responses, indicating their dependence on p75NTR 
signaling (Figures 4B and 4C). Under those conditions, BDNF-mediated JNK 
phosphorylation and cell death could be restored by introduction of a wild type p75NTR 
expression construct that is insensitive to our p75NTR shRNAs (Figures 4B and 4C). In 
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contrast to the wild type construct, the C257A mutant was unable to restore either JNK 
phosphorylation or cell death in response to BDNF in SCG neurons (Figures 4B and 
4C). Together, these results demonstrate that Cys257 is essential for p75NTR signaling in 
response to neurotrophins, and support the notion that disulphide-linked p75NTR dimers 
are the active, neurotrophin-sensitive receptor species in neurons. 
Cys257 is not required for downstream signaling by the p75NTR/NgR/Lingo-1 
complex in response to MAG 
The importance of Cys257 in neurotrophin-dependent p75NTR signaling prompted the 
question of its role in the activation of p75NTR by other types of ligands. We therefore 
tested the ability of wild type and mutant p75NTR to recruit RhoGDI and to increase 
RhoA activity in response to the myelin-derived ligand MAG. These activities require 
the presence of two additional receptor subunits, NgR and Lingo-1. Interestingly, cells 
expressing p75NTR, NgR and Lingo-1 responded equally well to stimulation with MAG in 
both RhoGDI recruitment to p75NTR (Figure 5A) and RhoA activity (Figure 5B) regardless 
of whether they received wild type or the C257A mutant. Thus, and in contrast to 
activation by neurotrophins, Cys257 is not required for the ability of p75NTR to signal in 
response to the non-neurotrophin ligand MAG, suggesting the existence of 
mechanistic differences in the activation of p75NTR by different ligands.  
Cys257 allows disulphide-linked p75NTR dimers to propagate conformational 
changes to intracellular domains following NGF binding 
How does Cys257 contribute to p75NTR signaling in response to neurotrophins? Its 
localization in the transmembrane domain suggested that it may play a role in the 
mechanism of receptor activation, either by regulating p75NTR oligomerization, or by 
allowing the propagation of conformational changes induced by neurotrophin binding. 
Although Cys257 clearly contributes to the formation of disulphide-linked p75NTR dimers, 
it remained unclear whether this was the primary determinant of receptor 
oligomerization. In particular, the ability of the C257A mutant to bind NGF at normal 
levels (Figure 1E) suggested that the mutation may not have disrupted the oligomeric 
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state of p75NTR at the cell surface, as this would have been expected to affect ligand 
binding affinity. In order to examine the possible role of non-covalent interactions in 
p75NTR oligomerization we performed chemical crosslinking studies of wild type and 
mutant cell surface receptors in living COS-7 cells. Following chemical crosslinking of 
cell surface proteins, p75NTR was immunoprecipitated from cell lysates, and then 
subjected to SDS/PAGE under reducing conditions, so that only oligomeric complexes 
stabilized by chemical crosslinking would be visualized. As expected, chemical 
crosslinking allowed the detection of wild type receptor dimers (Figure 6A), 
demonstrating that p75NTR indeed forms dimers at the surface of living cells in the 
absence of ligand. As chemical crosslinkers have only a limited efficiency, the actual 
proportion of receptor dimers and monomers at the cell surface can not be determined 
with this method. NGF binding did not alter the proportion of p75NTR dimers detected 
by chemical crosslinking in transfected cells (Figure 6A). Surprisingly, however, 
mutation of Cys257 did not affect the proportion of p75NTR dimers detected after 
chemical crosslinking, either in the absence or presence of NGF (Figure 6A). This 
indicated that p75NTR may still oligomerize in the absence of Cys257 through non-
covalent interactions.  
Inspection of the p75NTR transmembrane domain, revealed the presence of a relatively 
well conserved AxxxG266 motif (Figure 6B), which is characteristic of self-associating 
transmembrane domains, including those from integrins and glycophorin A (GpA) 
(Kubatzky et al., 2001). Interactions between isolated transmembrane domains can be 
studied in a biological membrane using the bacterial ToxCAT system (Russ and 
Engelman, 1999) (see Experimental Procedures for further details). Dimerization of wild 
type and mutant p75NTR transmembrane domains was assessed along with wild type 
GpA transmembrane domain, which is known for its strong self-association, and a GpA 
point mutant (G83I) that disrupts homodimerization, as positive and negative controls, 
respectively. The transmembrane domain of p75NTR was found to homodimerize in this 
system to about 60% of the level shown by GpA (Figure 6C). Mutation of Cys257 had 
only a small effect on transmembrane homodimerization (Figure 6C). In contrast, 
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mutation of Gly266 to Ile (G266I), which is analogous to the G83I in GpA, abolished self-
association of the p75NTR transmembrane domain (Figure 6C). When introduced in full-
length p75NTR together with C257A, the G266I mutation diminished the formation of 
p75NTR dimers at the plasma membrane (Figure 6D). Together, these data indicate that 
p75NTR homodimers can be stabilized at the cell surface by both covalent and non-
covalent interactions between transmembrane domains, and that the primary function 
of Cys257 is not in the formation of receptor dimers.  
We then considered the possibility that Cys257 may instead contribute to p75NTR 
signaling by mediating the propagation of conformational changes induced by 
neurotrophin binding. We reasoned that conformational changes involving alterations 
in the relative positions of p75NTR intracellular domains may be detected by 
fluorescence resonance energy transfer (FRET). Unlike methods based on enzyme 
complementation, in FRET, the transfer of energy between two chromophores 
depends both on the distance between them and their relative orientation, and it is 
therefore more suitable to quantitatively assess conformational rearrangements of 
receptor subunits in a complex. We chose homo-FRET over other more conventional 
FRET techniques because of its greater sensitivity and the advantage of using a single 
spectral variant to detect interactions between identical molecules (Squire et al., 2004). 
Homo-FRET can be detected as a decrease in steady-state fluorescence anisotropy 
that results from energy transfer between identical fluorophores. Monomeric Enhanced 
Green Fluorescent Protein (EGFP1) displays high anisotropy (i.e. low FRET), while a 
concatenated EGFP trimer (EGFP3) shows very low anisotropy (i.e. very high FRET), 
and they were used as negative and positive controls, respectively (Figures 7A, 7B and 
7E). Wild type and C257A p75NTR were tagged at the C-terminus with monomeric EGFP 
(see Experimental Procedures) and transfected in COS-7 cells. Anisotropy and total 
fluorescence were measured at different locations in the plasma membrane of 
transfected cells. At basal conditions, wild type p75NTR–EGFP displayed lower 
anisotropy than EGFP1 (i.e. higher FRET) at the plasma membrane (Figures 7C and 
7E), in agreement with its oligomeric state in living cells. Using the anisotropy value of 
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EGFP1 as baseline, the FRET level of wild type p75NTR–EGFP could be estimated to 
about 25% that of EGFP3 (Figure 7E), which gives a very strong FRET signal. Mutant 
C257A p75NTR–EGFP also showed lower anisotropy than EGFP1 at the cell surface, 
albeit not as much as wild type p75NTR (Figures 7D and 7E), which is in accordance 
with our crosslinking studies showing that this mutant retains the ability to form dimers 
at the plasma membrane. Interestingly, both p75NTR-EGFP constructs appeared mainly 
monomeric at intracellular locations (Figures 7C and 7D), suggesting that 
oligomerization occurs upon transit to the plasma membrane.  
NGF was added to cells expressing wild type and C257A p75NTR–EGFP and changes in 
anisotropy were evaluated by time-lapse microscopy. Acute addition of NGF produced 
an increase in anisotropy (i.e. decrease in FRET) at the plasma membrane of cells 
expressing wild type p75NTR–EGFP (Figure 7E). This anisotropy rise was observed in all 
cells examined (n=30), showed a consistent peak 2-3 minutes after NGF addition, and 
lasted for 3 to 10 minutes, waning towards the end of the recording (15 min) (Figures 
7F and 7G). In contrast, NGF had no effect on cell surface anisotropy in cells 
expressing the mutant C257A p75NTR–EGFP (n=22 cells examined) (Figures 7F and 7G). 
These results indicate that NGF induces a decrease in FRET in wild type p75NTR–EGFP 
at the plasma membrane, indicating  that receptor activation by neurotrophins involves 
conformational changes in the relative position or orientation of p75NTR intracellular 
domains. The inability of NGF to induce any change in FRET in cells expressing C257A 
p75NTR–EGFP correlates with the loss of neurotrophin-dependent p75NTR signaling in 
this mutant, and supports a role for Cys257 in the propagation of conformational 
changes induced by neurotrophin binding.  
 
DISCUSSION 
In this study, we have investigated the mechanism of activation of the p75 
neurotrophin receptor. The first major finding of this work is the ability of native p75NTR 
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to form disulphide-linked dimers through the conserved Cys257 in the transmembrane 
domain. The second is the unexpected requirement of this cysteine residue for the 
recruitment of intracellular effectors and downstream signaling by p75NTR in response 
to neurotrophins, but not in response to other ligands, such as MAG. The third is the 
ability of the p75NTR dimer to undergo a conformational change in response to NGF, 
and the essential role of Cys257 in this process. Based on these observations, we 
propose a novel mechanism of receptor activation involving ligand-induced 
rearrangement of disulphide-linked receptor subunits.  
While it is relatively straightforward to visualize how receptor kinases may become 
activated upon ligand binding (Schlessinger, 2002), this is less obvious for non-
catalytic receptors. Since these signal by selective interactions with intracellular 
effectors, the question that arises is how ligand binding regulates those interactions. 
Clearly, something ought to change in the receptor after ligand binding that makes its 
intracellular domain more or less prone to interact with downstream effectors. Ligand 
binding may change the oligomerization state of the receptor —by, for example, 
inducing dimers— leading to cooperative binding or release of downstream effectors. 
Although this has been the prevalent model for p75NTR activation to date, our results 
show that the active p75NTR species pre-exists as a disulphide-linked dimer which is 
essential for downstream signaling in response to neurotrophins, obviating a classical 
ligand-mediated dimerization mechanism. Although an earlier study using artificially 
deglycosylated p75NTR extracellular domain had suggested that NGF may activate a 
preformed receptor dimer by inducing its dissociation into monomers (He and Garcia, 
2004), more recent work has clearly shown that glycosylated p75NTR extracellular 
domain is monomeric in the absence of ligand, and that NGF interacts with p75NTR 
dimers, not monomers (Gong et al., 2008). Another possible mechanism for receptor 
activation is that ligand binding changes the relative orientation of receptor subunits in 
a dimeric or multimeric receptor complex. In some cytokine and growth factor 
receptors, this is achieved through the relative rotation of their transmembrane 
domains within the plane of the membrane (Moriki et al., 2001; Seubert et al., 2003). In 
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the case of p75NTR, however, the disulphide link formed by Cys257 in the transmembrane 
domain clearly restricts the possibilities for relative movement of receptor subunits.  
Our FRET experiments indicate that the two intracellular domains of the p75NTR dimer 
are in close proximity under basal conditions. This is in agreement with data from a 
recent study using a β-gal complementation strategy (Wehrman et al., 2007). Unlike 
FRET, however, enzyme complementation gives an all-or-none response at the single 
molecule level, and is hence less suited to reveal subtle conformational changes that 
do not alter the oligomeric state of the receptor. In our experiments, we observed a 
consistent decrease in FRET upon NGF binding to wild type p75NTR. This could either 
result from a separation of p75NTR intracellular domains or changes in their relative 
orientation due to rotation of receptor subunits. Although these two possibilities are not 
mutually exclusive, it is difficult to envision how changes in the relative orientation of 
intracellular domains can be brought about by ligand binding to the extracellular region 
of a dimeric receptor that is covalently crosslinked at the plasma membrane. As 
explained above, a disulphide bridge linking the transmembrane regions of two 
receptor subunits would clearly prevent the propagation of rotational movements from 
the extracellular to the intracellular domains. Thus, we believe that the decrease in 
FRET observed after NGF binding most likely reflects the separation of p75NTR 
intracellular domains. Importantly, and in contrast to the wild type receptor, we found 
no evidence of NGF-mediated conformational changes in the intracellular domain of 
the C257A p75NTR mutant. Based on these observations, we propose that neurotrophin 
binding produces a scissors-like movement of disulphide-linked p75NTR subunits with 
the Cys257–Cys257 disulphide link acting as the fulcrum, thereby altering the relative 
proximity of intracellular domains (Figure 8). In this model, Cys257 would function as the 
pin in the scissors: in its absence, relative movements at one end can not be 
propagated to the other. Unlike normal scissors, however, our results suggest that as 
the extracellular domains come closer together on binding to the neurotrophin dimer, 
the intracellular domains separate, not unlike a “snail-tong” mechanism (Figure 8). This 
type of movement could be achieved if the p75NTR protein were to be kinked, as 
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opposed to straight, relative to the plane of the plasma membrane, in the vicinity of 
Cys257. Proline residues are known to introduce kinks that may vary from 5 to 50 
degrees, and are common in transmembrane helices (Yohannan et al., 2004). Thus, the 
highly conserved Pro254, three residues upstream of Cys257 (see Figure 1C), seems like 
a good candidate for such function. Although not as well conserved, an unusual Pro 
triad is also present in the intracellular juxtamembrane region of p75NTR, 20 residues 
away from the plasma membrane (Pro295-Pro296-Pro297). This portion of p75NTR is not 
known to be helical in vivo, and has been characterized by nuclear magnetic 
resonance as unstructured in solution (Liepinsh et al., 1997). The conformational 
changes inferred from our FRET experiments require a relatively rigid structure 
connecting the extra and intracellular domains, and suggest that the juxtamembrane 
region of p75NTR may be stabilized in vivo by interaction with other intracellular 
components.  
The conformational changes observed upon NGF binding showed a characteristic 
maximum at 2-3 minutes after NGF addition and lasted for an additional 3 to 10 
minutes. This kinetics is consistent with the onset of p75NTR internalization and 
downstream signaling, which requires at least 15 min after ligand stimulation 
(Bronfman et al., 2003). The separation of intracellular domains induced by NGF 
binding may facilitate the recruitment of downstream effectors by exposing 
determinants important for their interaction with the receptor. This may be particularly 
important for receptors with relatively small intracellular domains, such as p75NTR. 
Weak homotypic interactions between these domains may keep the receptor in a 
closed, inactive state, and could potentially explain the residual amount of dimers 
observed after simultaneous mutation of Cys257 and Gly266. Although the p75NTR death 
domain was found to be monomeric in solution up to 2.5 mM (Liepinsh et al., 1997), 
such interactions might be detected in crystallization experiments. Even though it is 
unclear at present why the conformational change observed is not sustained for longer 
periods of time, the variation observed in its duration could reflect interactions with 
different effector molecules or activation of different downstream signaling events. That 
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p75NTR activation involves separation of intracellular domains is consistent with a 
previous study using chimeric intracellular domains artificially tethered to the plasma 
membrane that were induced to dimerize by addition of a dimeric drug (Wang et al., 
2000). In this work, dimerization inhibited the proapoptotic effect of the constructs, 
from which the authors inferred that neurotrophin-mediated receptor dimerization 
should likewise silence p75NTR activity, a conclusion that was at odds with the bulk of 
studies in the field. Our results indicating that p75NTR is already dimeric before ligand 
binding and that p75NTR activation by NGF involves the separation of intracellular 
domains reconcile those results and suggest that this is in fact the way in which 
neurotrophins activate this receptor.  
Previous work has shown that p75NTR can enhance Trk responses to neurotrophins, 
particularly when these are present at limiting concentrations. For example, sensory 
and sympathetic neurons from p75NTR knock-out mice show reduced resposiveness to 
NGF (Lee et al., 1994), and a mutant NGF unable to bind p75NTR displays lower binding 
affinity and reduced biological activity in PC12 cells and sensory and sympathetic 
neurons (Rydén et al., 1997a). This positive modulatory role of p75NTR on neurotrophin 
activities mediated by Trk receptors has been attributed to receptor-receptor 
interactions and/or ligand concentration or presentation effects. It is unclear at present 
whether these activities require disulphide-linked dimerization of p75NTR. Given the 
proposed role for the TrkA and p75NTR transmembrane domains in their functional 
interaction (Esposito et al., 2001), it is possible that formation of high-affinity NGF 
binding sites may be sensitive to conformational changes mediated by Cys257.  
The fact that p75NTR signaling in response to MAG does not require Cys257 suggests 
that myelin-derived ligands activate p75NTR by a different mechanism. Although our 
results indicate that disulphide-linked dimerization is important for p75NTR activation by 
neurotrophins, the stoichiometry of the complex formed by p75NTR, NgR and Lingo-1 
needs to be further investigated. The lack of involvement of Cys257 in signaling by MAG 
opens an opportunity to specifically disrupt neurotrophin-specific p75NTR effects in 
 16 
loss-of-function studies. Intriguingly, we found that the proportion of cell surface 
disulphide-linked p75NTR dimers varied in different cell types and with different levels of 
receptor expression. As only such dimers are able to respond to neurotrophins, 
changes in their proportion or abundance at the cell surface, e.g. between different cell 
types or in response to external stimuli or redox states, could determine the relative 
degree of p75NTR responsiveness to different ligands.  
Cys257 represents a critical element in the activation mechanism of p75NTR by 
neurotrophins and is absolutely conserved in all vertebrate and invertebrate p75NTR 
molecules isolated so far (Bothwell, 2006). We propose that neurotrophins neither 
activate p75NTR by inducing receptor dimers or disassembly into monomers, as 
previously suggested, but through a novel mechanism involving the rearrangement of 
disulphide-linked receptor subunits. Many receptors in the TNFR superfamily —to 
which p75NTR belongs— bear intramembrane cysteines, including Fas, DR6, RANK, 
RELT, BCM, TACI, CD30, CD40 and receptors for TNF, lymphotoxin beta and TRAIL. 
The “snail-tong” mechanism described here could therefore represent a general way 
by which receptors bearing intramembrane cysteines are activated.  
 
EXPERIMENTAL PROCEDURES 
Plasmids, antibodies , proteins and chemicals 
Rat p75NTR was expressed from the pCDNA3 vector backbone (Invitrogen) using a full-
length coding sequence flanked by an N-terminal hemagglutinin (HA) epitope tag. 
Mutations were introduced using QuickChange (Stratagene) and verified by DNA 
sequencing. Plasmids to express RIP2, TRAF6, NRIF, sortilin, Lingo-1 and RhoGDI 
were previously described. EGFP plasmid was from Clontech. Luciferase reporter 
plasmid for NF-κB was from Promega. The origin of antibodies were as follows: 
MC192 anti-p75NTR from Phil Barker; anti-HA from Roche; anti-myc, anti-phospho and 
-total JNK, cleavage-specific anti-caspase-3, anti-RhoA and anti-RhoGDI from Cell 
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Signaling; anti-tubulin from Sigma; anti-RIP2 from Santa Cruz. NGF was purchased 
from Alomone Labs, MAG-Fc and Nogo peptide from R&D. NGF was typically applied 
at 100 ng/ml for 30 minutes unless otherwise indicated. MAG-Fc was used at 25 µg/ml 
for 30 minutes. PMA was used at 200 nM for 1 h. Epoxomycin (1 µM) and DAPT (2 µM) 
were applied 1.5 h prior to PMA. All compounds were from Sigma.   
Cell transfection and tissue culture 
COS-7 cells were transfected with polyethylenimine (PEI). HEK293 and M23 cells were 
transfected with Lipofectamine 2000 (Gibco). M23 is a clonal derivative of MG87 cells 
(Eketjäll et al., 1999), originally derived from mouse NIH3T3 fibroblasts. Cells were 
typically used on the 2nd day after transfection for short-term signaling assays, at which 
point cell death was still low or undetectable. We found that different signaling assays 
worked best in different cell lines: RhoA and RhoGDI in COS-7, NF-κB in M23 and P-
JNK and caspase-3 in HEK293 cells. This may be related to the specific complement 
of downstream effectors expressed by each cell type. Cell lines were cultured under 
standard conditions and primary neurons in serum-free, N2-supplemented DMEM:F12 
medium (Gibco).  
Sympathetic neuron culture and p75NTR shRNAs 
Sympathetic neurons from P4 rat SCGs were cultured and transfected with control or 
p75NTR shRNAs alone or co-transfected with wild type or mutant p75NTR as previously 
described (Kenchappa et al., 2006; Palmada et al., 2002). The target sequence of the 
first p75NTR shRNA was ACGGACCTATCTGAGCTGAAA, the second was 
ATGGCGTGACTTTCAGGGAAA. Control shRNA was targeted against EGFP 
sequences. Three days after transfection neurons were treated with 200 ng/ml of 
BDNF for 1 hr and lysed in NP-40 buffer (10% glycerol, 50 mM Tris-HCl pH 7.5, 150 
mM NaCl, 1% NP-40,, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride (PMSF), 2 
mg/ml leupeptin and aprotinin) to assess JNK activation.  For cell survival assay the 
cells were fixed in 4% paraformaldehyde 48 hrs after BDNF treatment and scored for 
apoptosis as previously described (Kenchappa et al., 2006). 
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Biotinylation, immunoprecipitation, immunoblotting and chemical crosslinking 
Cell surface proteins were biotinylated with Sulfo-NHS-LC-Biotin (Pierce). Cells were 
lysed in buffer containing 1% Triton X-100, 60 mM octyl-glucosyde, 10 mM 
iodoacetamide and protease inhibitors (Roche). For reducing conditions, 
immunoprecipitates were boiled in sample buffer containing 1M DTT. Gels were 
blotted to PVDF membranes (Amersham). Biotinylated proteins were detected using 
Neutravidin conjugated to Alkaline Phosphatase (Sigma). Filters were developed by 
chemifluoresence (Amersham) and scanned on a STORM840 fluorimager 
(MolDynamics). Radioiodination of NGF was done with lactoperoxidase (Sigma), and 
EDAC/SulfoNHS (Pierce) was used as chemical crosslinker. Autoradiography was done 
on a STORM840 phosphorimager. Quantifications of immunoblots and autoradiograms 
were done with ImageQuant software (MolDynamics).  
Assays of NF-kB, RhoA and cell death 
NF-κB activity was assayed using a luciferase reporter kit (Promega). NGF was added 
2 days after transfection and left for 24 h prior to cell lysis. RhoA activity was evaluated 
using a kit from Cytoskeleton. Cell death was assessed by the TUNEL method using 
kits from Roche and Biocolor. NGF was added 2 days after transfection and left for 
another day in serum free-medium prior to assay of cell death.  
ToxCAT assay of self-association of transmembrane domains 
The reporter system exploits the ability of the ToxR transcription activator of the Vibrio 
Cholerae pathogen to bind the cholera toxin (ctx) gene promoter only when dimerized. 
A transmembrane segment of interest fused to ToxR is delivered to the bacterial inner 
membrane by fusion to maltose-binding protein (MBP). Varying amounts of ToxR 
dimers will be formed in the cytosol in direct proportion to the oligomerization ability of 
the TM domain. Binding of dimerized ToxR to the ctx DNA element triggers expression 
of a chloramphenicol transferase (cat) gene reporter and production of CAT protein, 
which can then be quantified by a CAT-ELISA kit (Roche Diagnostics) as described by 
McClain et al. (McClain et al., 2003). Expression levels of different ToxR-TM-MBP 
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chimeras were determined by Western blotting. The ToxR and ToxCAT systems have 
been previously applied to demonstrate self-association of a range of TM domains 
from glycophorin A (GpA) (Kubatzky et al., 2001), integrin αIIb (Li et al., 2004), ErbB1 to 
4 (Mendrola et al., 2002), and the Epo receptor (Kubatzky et al., 2001).  
Anisotropy microscopy and FRET 
Anisotropy microscopy was done as described by Squire et al. (Squire et al., 2004) in 
transiently transfected COS-7 cells. Images were acquired 15-24 h post-transfection, 
using a Olympus IX81 inverted microscope (Olympus, Germany) equipped with a MT20 
illumination system. A linear dichroic polarizer (Meadowlark Optics, Frederick, 
Colorado, US) was placed in the illumination path of the microscope, and two identical 
polarizers were placed in an external filter wheel at orientations parallel and 
perpendicular to the polarization of the excitation light. The fluorescence was collected 
via a 20X 0.7 NA air objective, and parallel and polarized emission images were 
acquired sequentially on an Orca CCD camera (Hamamatsu Photonics, Japan). Data 
acquisition was controlled by the CellR software supplied by the microscope 
manufacturer. NGF (or vehicle) was added 1 min after the start of the time-lapse at a 
concentration of 100 ng/ml. Anisotropy values were extracted from image stacks of 30 
images acquired in both parallel and perpendicular emission modes every 30 sec for a 
time period of 15 min after NGF addition. For each consrtuct, 2 areas per field of view 
were measured in 4 independent trasnfections performed in duplicate or triplicate. 
Fluorescence intensity and anisotropy images were calculated as described by Squire 
et al. (Squire et al., 2004). Wild type and C257A p75NTR constructs were tagged at the 
C-terminus with a monomeric version of EGFP (Clontech) carrying the A207K mutation 
that disrupts EGFP dimerization. A cytosolic EGFP monomer (EGFP1) gave a mean 
anisotropy value of 0.295 ± 0.005 (no FRET), and a concatenated EGFP trimer (EGFP3) 
gave a value of 0.2369 ± 0.013 (maximal FRET), so thresholds for image analysis (done 
with Image J software) were set between 0.2 and 0.35 (Figure 7A to D).  
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FIGURE LEGENDS 
Figure 1. Transmembrane Cys257 mediates formation of disulphide-linked p75NTR 
dimers 
(A) Cell surface expression of disulphide-linked p75NTR dimers (dim) and monomers 
(mon) in transfected COS-7 cells visualized by Neutravidin probing of p75NTR 
immunoprecipitates under non-reducing (–DTT) and reducing (+DTT) conditions. In 
non-reducing conditions, p75NTR dimers run somewhat higher, and monomers lower, 
than their predicted molecular weights.  
(B) Cell surface expression of disulphide-linked p75NTR dimers (dim) and monomers 
(mon) in COS-7 cells transfected with different amounts of wild type p75NTR. 
Immunoprecipitates were electrophoresed under non-reducing conditions and p75NTR 
was visualized by Neutravidin probing of p75NTR immunoprecipitates. Results are 
expressed as mean dimer/monomer ratio.  
(C) Alignment of p75NTR transmembrane domain sequences from vertebrate and 
invertebrate species.  
(D) Cell surface expression of endogenous disulphide-linked p75NTR dimers (dim) and 
monomers (mon) in PC12 cells, RN22 Schwannoma cells and SCG sympathetic 
neurons visualized by Neutravidin probing of p75NTR immunoprecipitates. Control, 
untransfected COS cells.  
(E) Expression of endogenous disulphide-linked p75NTR dimers (dim) and monomers 
(mon) in extracts of newborn rat cerebellum (cblm), cortex (ctx) and hippocampus (hc) 
visualized by immunoblotting of p75NTR immunoprecipitates under reducing and non-
reducing conditions. The control lane represents a mock immunoprecipitate of the 
cblm extract.  
(F) Binding of 125I-NGF to wild type and C257A p75NTR analyzed by chemical 
crosslinking. Samples were run under reducing conditions. For each construct, binding 
counts were normalized to levels of expression as assessed by immunoblotting (IB). 
Results are expressed as mean ± SD of three independent determinations.  
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(G) γ-secretase-dependent intramembrane cleavage of C257A p75NTR following 
stimulation with PMA in transfected COS cells. The proteasome inhibitor epoxomycin 
was used to prevent degradation of CTF and ICD fragments. Mutant and wild type (wt) 
p75NTR molecules were recovered by immunoprecipitation and visualized by 
immunoblotting. The γ-secretase inhibitor DAPT blocked the generation of p75NTR 
intracellular domain (ICD). CTF, carboxy terminal fragment.  
 
Figure 2. Cys257 is essential for recruitment of NRIF and TRAF6 to p75NTR in 
response to NGF 
(A) Binding of NRIF to wild type and mutant p75NTR in transfected HEK293 cells 
assayed by immunoprecipitation (IP) and immunoblotting (IB).  
(B) Binding of TRAF6 to wild type and mutant p75NTR in transfected HEK293 cells.  
(C) Binding of NRIF to wild type and mutant p75NTR in transfected HEK293 cells. Prior 
to gel electrophoresis, the pull-down sample was splitted in two equal parts, one was 
boiled in sample buffer, the other was treated with 1M DTT prior to boiling. The 
migration of p75NTR dimers and monomers is indicated.  
(D) Binding of TRAF6 to wild type and mutant p75NTR in transfected HEK293 cells 
analyzed as in panel (C).  
(E) Binding of NRIF to wild type and mutant p75NTR in rat SCG neurons. NRIF only 
interacts with p75NTR disulphide-linked dimers, not monomers.  
 
Figure 3. Cys257 is essential for p75NTR signaling to NF-κB, caspase-3 and cell 
death in response to NGF 
(A) NF-κB activity in transfected M23 fibroblasts in the presence and absence of NGF.  
(B) Activation of caspase-3 visualized with a cleavage-specific antibody in HEK293 
cells transfected with p75NTR constructs in response to NGF. Reprobing controls for 
p75NTR and GAPDH are shown. Independent experiments confirmed comparable 
expression of transfected p75NTR constructs.  
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(C) Cell death assay in HEK293 cells transfected with p75NTR constructs in response to 
NGF. Results are expressed as mean ± SD of three independent experiments, each 
performed in duplicate.  
 
Figure 4. Cys257 is essential for p75NTR signaling in SCG neurons 
(A) Downregulation of p75NTR expression in rat SCG neurons following transfection of 
p75NTR shRNAs.  
(B) Assay of JNK phosphorylation in SCG neurons in response to BDNF. SCG neurons 
were transfected with the indicated shRNA constructs. In rescue experiments, wild 
type p75NTR or C257A p75NTR constructs insensitive to p75NTR shRNAs were also 
introduced by DNA transfection. JNK phosphorylation was assessed by 
immunoblotting of total cell lysates.  
(C) Cell death in SCG neurons transfected with p75NTR shRNAs in response to BDNF. 
Rescue experiments with wild type and C257A p75NTR constructs were performed as 
above. *, p<0.05 vs. wild type, n=3. 
Figure 5. Cys257 is not required for downstream signaling by the 
p75NTR/NgR/Lingo-1 complex in response to MAG 
(A) Binding of RhoGDI to wild type and C257A p75NTR in COS-7 cells co-transfected 
with NgR and Lingo-1 and stimulated with MAG-Fc.  
(B) RhoA activity in COS-7 cells transfected with wild type and mutant p75NTR in the 
presence of NgR and Lingo-1 after stimulation with MAG-Fc for 30 min. Results are 
expressed as mean ± SD relative to wild type without MAG treatment. *, p<0.05 vs. 
control, n=3.  
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Figure 6. Cell surface p75NTR dimerization is mediated by covalent and non-
covalent interactions between transmembrane domains 
(A) Wild type and C257A p75NTR dimers analyzed by cell surface chemical crosslinking 
under reducing conditions. Cell lysates were immunoprecipitated with anti-p75NTR 
antibodies; immunoblot was probed with anti-HA antibodies.  
(B) Alignment of p75NTR transmembrane domains highlighting the AxxxG self-
association motif and Gly266.  
(C) ToxCAT assay of self-association of wild type and mutant p75NTR transmembrane 
domains. Wild type and mutant transmembrane domains from glycophorin A (GpATM) 
were used as positive and negative controls, respectively.  
(D) Wild type and mutant p75NTR dimers analyzed by cell surface chemical crosslinking 
as above.  
 
Figure 7. Analysis of conformational changes in p75NTR intracellular domains by 
anisotropy microscopy 
(A-D) Steady-state anisotropy in transfected cells. Examples of areas used for 
anisotropy measurements are boxed and shown as high magnification insets. 
Monomeric EGFP (EGFP1, high anisotropy, low FRET) and a concatenated EGFP 
trimer (EGFP3, low anisotropy, high FRET) were used as controls. The calibration bar 
of the look-up table is shown below.  
(E) Steady-state anisotropy of wild type and C257A p75NTR-EGFP in COS-7 cells. The 
anisotropy value of EGFP1 was arbitrarily set to zero and used as baseline for the 
histogram. Bars show average ± SD (n=8-11 cells for EGFP and 22-30 cells for p75NTR). 
(F) Representative examples of anisotropy traces after addition of NGF or medium in 
cells expressing wild type or C257A p75NTR-EGFP. A peak in anisotropy was observed  
after NGF addition in all cells expressing wild type p75NTR that were examined (n=30) 
regardless of their initial baseline anisotropy level.  
 30 
(G) Anisotropy change after addition of NGF or medium (control). The difference in 
anisotropy before and after addition of NGF (i.e. peak minus baseline value) or medium 
was calculated for wild type and C257A p75NTR-EGFP. Results are expressed as 
average ± SD (n=15 to 17 cells examined). *, p<0.0001 vs. C257A.  
 
Figure 8. The “snail-tong” mechanism of p75NTR activation in response to 
neurotrophins 
Hypothetical schematic of p75NTR in the cell membrane before and after neurotrophin 
binding (adapted from Gong et al. (2008) and Liepinsh et al. (1997)). The approximate 
position of Cys257 is indicated. Arrows denote the postulated “snail-tong” movement of 
p75NTR subunits initiated by ligand binding: closing onto the neurotrophin dimer in the 
outside, opening in the inside.  
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